Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Unlicensed Transdermal Medications in Feline Patients: Three Case Reports

Author(s):  Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael

Issue:  Nov/Dec 2022 - Volume 26, Number 6
View All Articles in Issue

Abstract:  In veterinary clinical practice, conventional pharmacological treatments such as commercial capsules, tablets, or oral liquids may be difficult to administer to feline patients. Noncompliance, which is estimated to account for the majority of treatment failures, may potentially be overcome with alternative, customized treat- ment options such as topically applied, permeation-enhancing (transdermal) unlicensed medications. These medications allow for the percutaneous absorption of drugs into and through the animal’s skin, bypassing the first-pass metabolism, potentially allowing for greater bioavailability, and thus decreasing dosage to achieve therapeutic effects. In these case reports, the efficacy of two unlicensed transdermal medications is demonstrated by the successful treatment of three feline patients, refractory to conventional pharmacotherapy. In case 1, the veterinary physician prescribed gabapentin 10 mg/0.1 mL topical Lipoderm, a permeation-enhancing base, to be applied three times a day inside the cat’s ear, in order to manage the unconscious fits following a road traffic accident. In cases 2 and 3, two cats were prescribed fluoxetine 40-mg/g topical Lipoderm, to be applied once a day, in order to manage the inappropriate behavior (urination and defecation). Following three months of transdermal treatment, the quality of life of the three cats and their owners increased considerably, as demonstrated by the results of the validated, Health Related Quality of Life questionnaires employed before treatment (retrospectively) and after treatment. Permeation-enhancing (transdermal) medications are a promising dosage form in veterinary pharmacotherapy. The benefits and versatility of these alternative, customized treatment options are worth considering in current therapeutics.

Related Keywords: Craig Urwin, BSc (Hons), Linda Jean, BPharm, ARPharmS, Maria Carvalho, PharmD, MRPharmS, PhD, Michael Robson-Laws, BSc (Hons), veterinary compounding, case reports, cats, felines, topical preparations, transdermal administration, permeation-enhancing excipients, seizure disorder, gabapentin, formulations, behavioral disorders, inappropriate urination and defecation, fluoxetine

Related Categories: EXCIPIENTS, FORMULATIONS, VETERINARY, CASE REPORTS, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version




Download in electronic PDF format for $55

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Veterinary Transdermal Medications: A to Z Davidson Gigi S Mar/Apr 2003 106-113 Buy
Unlicensed Transdermal Medications in Feline Patients: Three Case Reports Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael Nov/Dec 2022 468-472 Buy
Investigation of Filler Effects on the Compounding of Freeze-dried Orodispersible Tablets Containing Annona muricata Extract Azman Syahiera Ezzah Noor, Abd Razak Fashli Syafiq, Kamal Wan Hamirul Bahrin Wan, Zheng Gan Kok, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai Nov/Dec 2020 509-514 Buy
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases Mixon William, Helms Scott R Sep/Oct 2008 392-397 Buy
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report Jones Nat, Carvalho Maria, Branvold-Herr Andrea May/Jun 2017 205-211 Buy
Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets Mahesparan Vishnu A/L, Bin Abd Razak Fashli Syafiq, Ming Long Chiau, Uddin ABM Helal, Sarker Md Zaidul Islam, Bin Liew Kai Mar/Apr 2020 148-155 Buy
Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane Jan/Feb 2017 22-27 Buy
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc Jan/Feb 2014 6-12 Buy
Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin Rudner Shara, Browne Paul Nov/Dec 2010 488-491 Buy
Investigation of the Effects of Excipients in the Compounding of Amlodipine Besylate Orally Disintegrating Tablets Azmi Nurual Hanisah Saiful, Ming Long Chiau, Uddin A.B.M. Helal, Sarker Zaidul Islam, Bin Liew Kai Jan/Feb 2022 80-87 Buy